Heredodejeneratif Hastalıklara Genetik Yaklaşım
Özet
Heredodejeneratif hastalıklar, santral sinir sisteminin ilerleyici dejenerasyonu ile karakterize, oldukça heterojen ve genetik kökenli bozukluklardır. Tanıda başlangıç yaşı, klinik öykü ve ayrıntılı fizik muayene temel rol oynarken, modern moleküler genetik yöntemler kesin teşhis için kritik öneme sahiptir. Multidisipliner bir yaklaşımla klinik genetik uzmanlarının sürece dahil edilmesi, hastalıkların prognozunu öngörmek, etkili tedavi stratejileri geliştirmek ve ailelere doğru genetik danışmanlık hizmeti sunmak için zorunludur.
Heredodegenerative disorders are a heterogeneous group of genetically determined conditions characterized by the progressive degeneration of the central nervous system. Accurate diagnosis relies on early clinical assessment, detailed medical history, and physical examinations, which are further supported by advancements in molecular genetic testing. Implementing a multidisciplinary approach involving clinical geneticists is essential for determining prognosis, guiding therapeutic interventions, and providing appropriate genetic counseling to affected families.
Referanslar
Arce VSA, Plana JC, Arzimanoglou A, Ouvrier R. Heredodegenerative Disorders. In Arzimanoglou A, O′ Hare A, Johnston MV, Ouvrier R ed. Clinics in Developmental Medicine, Aicardi’s Diseases of the Nervous System in Childhood. 4th Editio. Sydney,Australia: Mac Keith Press; 2018.p.471-541.
Heredodegenerative Disorders, Nervous System. 2021 MedGen UID: 155945 Concept ID: C0751870 (https://www.ncbi.nlm.nih.gov/medgen/155945#Definition).
Boddaert N, Brunelle F, Desguerre I. Clinical and imaging diagnosis for heredodegenerative diseases. Handb Clin Neurol. 2013; 111:63-78.
Zeybek S, Sağ ŞÖ, Temel ŞG. Genel Gelişimsel Gecikme/Zihinsel Yetersizlik (Genetik Yaklaşım). Ergün Çil ed. Çocuklarda Bulgudan Tanıya Algoritmalar, Güncellenmiş ve Genişletilmiş 2.Baskı. İstanbul: İstanbul Tıp Kitabevleri; 2021.p.254-257.
Dugoff L, NortonME, Kuller JA. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016; 215(4): B2-B9.
Keogh MJ, Jaiser SR, Steele HE, Horvath R, Chinnery PF, Baker MR. PLP1 mutations and central demyelination: Evidence from electrophysiologic phenotyping in female manifesting carriers. Neurol Clin Pract. 2017; 7:451–54.
NI Wolf, RML van Spaendonk, GM Hobson, Kamholz J. PLP1 Disorders. 1999 Jun 15 [Updated 2019 Dec 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1182/
Garbern JY, Hobson GM. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol. 2012;32(1):62-67.
Feinstein M, Markus B, Noyman I et.al. Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am J Hum Genet. 2010;87: 820-28.
Srivastava S, Waldman A, Naidu S. Alexander Disease. 2002 Nov 15 [Updated 2020 Nov 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1172/
Springer S, Erlewein R, Naegele T et al. Alexander disease – classification revisited and isolation of a neonatal form. Neuropediatrics. 2000;31:86–92.
Karikkineth AC, Scheibye-Knudsen M, Fivenson E, Croteau DL, Bohr VA. Cockayne syndrome: Clinical features, model systems and pathways. Ageing Res Rev. 2017;33:3-17.
Moriwaki S. Cockayne Syndrome. Brain Nerve. 2019;71(4):390-93.
Patel R. Genetic Diagnosis of Cockayne Syndrome. Pediatr Neurol Briefs. 2020;34:9.
Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA. Lafora disease - from pathogenesis to treatment strategies. Nat Rev Neurol. 2018;14(10):606-17.
Jansen AC, Andermann E. Progressive Myoclonus Epilepsy, Lafora Type. 2007 Dec 28 [Updated 2019 Feb 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1389/
Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, Minassian BA. Lafora disease Epileptic Disord. 2016;18(S2):38-62.
Haekins-Salsbury J, Cooper DJ, Sands MS. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease). Biochim Biophys Acta. 2013;1832(11):1906-1909.
Warrier V, VieiraM, Mole SE. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. Biochim Biophys Acta. 2013;1832(11):1827-30.
Chen CP, Lin SP, Chern SR, Lee CC, Huang JK, Wang W. Direct transmission of the 18q- syndrome from mother to daughter. Genet Counsel. 2006;17: 185-89.
